Next Article in Journal
Role of Leukotrienes and Leukotriene Modifiers in Asthma
Next Article in Special Issue
Drug Induced Hypersensitivity and the HLA Complex
Previous Article in Journal
Aptamers for Targeted Drug Delivery
Previous Article in Special Issue
Beyond Genetics—Stratified and Personalised Medicines Using Multiple Parameters
Open AccessReview

The Pharmacogenomics of Anti-Hypertensive Therapy

BHF Glasgow Cardiovascular Research Centre, 126 University Place, University of Glasgow, Glasgow G12 8TA, UK
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2010, 3(6), 1779-1791; https://doi.org/10.3390/ph3061779
Received: 2 March 2010 / Revised: 20 May 2010 / Accepted: 26 May 2010 / Published: 1 June 2010
(This article belongs to the Special Issue Personalized Medicine)
Hypertension is a major public health problem, but measures to reduce blood pressure and thus cardiovascular risk are complicated by the high prevalence of treatment resistance, despite the availability of multiple drugs. Drug side-effects contribute considerably to suboptimal blood pressure control. Clinicians must often rely on empirical methods to match patients with effective drug treatment. Hypertension pharmacogenomics seeks to find genetic predictors of response to drugs that lower blood pressure and to translate this knowledge into clinical practice. In this review we summarise the current status of hypertension pharmacogenetics from monogenic hypertension to essential hypertension and discuss the issues that need to be considered in a hypertension pharmacogenomic study. View Full-Text
Keywords: hypertension; pharmacogenetics; pharmacogenomics; beta-blockers; ACE inhibitors; angiotensin receptor blockers; antihypertensive; calcium channel blockers; thiazide diuretics hypertension; pharmacogenetics; pharmacogenomics; beta-blockers; ACE inhibitors; angiotensin receptor blockers; antihypertensive; calcium channel blockers; thiazide diuretics
Show Figures

Figure 1

MDPI and ACS Style

Padmanabhan, S.; Paul, L.; Dominczak, A.F. The Pharmacogenomics of Anti-Hypertensive Therapy. Pharmaceuticals 2010, 3, 1779-1791.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop